Trials / Completed
CompletedNCT04500964
Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve
Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve. An International Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 173 (actual)
- Sponsor
- IRCCS Policlinico S. Donato · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR). The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes. The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TAVR | Trancatheter aortic valve replacement |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2020-01-01
- Completion
- 2020-07-01
- First posted
- 2020-08-06
- Last updated
- 2023-10-17
Locations
1 site across 1 country: Italy
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04500964. Inclusion in this directory is not an endorsement.